Libraries and the R&D strategy: a way forward
✍ Scribed by MARGARET HAINES
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 761 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1471-1834
No coin nor oath required. For personal study only.
✦ Synopsis
As guest editor for the Decembrer 1994 issue of Health Libraries Review, I chose the theme of Evidence‐Based Practice. In my editorial I suggested that Evidence‐based Practice offered tremendous opportunities for NHS librarians to demonstrate their skills in supporting a knowledge‐based NHS, because many clinicians had complained that they did not have the time, retrieval skills or knowledge of relevant information resources to be effective at finding scientific evidence. Librarians, on the other hand have advanced online searching skills, rapid document retrieval and delivery services, and up‐to‐date knowledge of the world's medical information resources and networks. These skills mean that librarians are not only well‐placed to support clinicians in finding and sifting scientific evidence, but also in teaching clinicians how to search for and store information themselves.
NHS librarians have not been slow to recognize these opportunities and innovative professinal development programmes have appeared to help hone their skills, such as the Librarian of the 21st Century Programme in the Anglia and Oxford region. The success of NHS librarians in supporting evidence‐based health care has led to their formal involvement in evidence‐based medicine workshops for clinicians in a number of regions.
In March 1996, as NHS Library Adviser, I was asked to prepare a paper for the R&D Board of the NHS Executive about how this library support could be formally integrated into the R&D Strategy. My paper was unanimously endorsed by the Board and later by the Central R&D Committee of the NHS Executive. It suggests principles of library provision in support of R&D and is reprinted below.
📜 SIMILAR VOLUMES
Tremendous advances in our understanding of pathogenesis of amyotrophic lateral sclerosis (ALS) have provided a rich pipeline of drugs for clinical trialists. At least 32 unique compounds have been tested. Nevertheless, riluzole is currently the only treatment that prolongs survival. We present a cr
**After rising from poverty to earn a Harvard degree, an Appalachian lawyer pays tribute to the strong "hill women" who raised and inspired her, and whose values have the potential to rejuvenate a struggling region --an uplifting and eye-opening memoir for readers of _Hillbilly Elegy_ and _Educated_